Sichuan Pearl Pharmaceutical Co., Ltd.

A human bioequivalence study was conducted using the tauroursodeoxycholic acid capsules provided by Sichuan Kelun Pharmaceutical Co., Ltd. as the test preparation and the tauroursodeoxycholic acid capsules produced by the original manufacturer, Italian Besti Pharmaceuticals, as the reference preparation. The relative bioavailability of the test preparation was calculated and the bioequivalence of the two preparations was compared.

To preliminarily evaluate the efficacy and safety of blue hawthorn glycoside capsules in the treatment of dyslipidemia; to explore the clinical efficacy of different doses of blue hawthorn glycoside capsules in the treatment of dyslipidemia.